Clinical Trials · NCT02809105
A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Astellas Pharma Inc
- Enrollment
- 186
- Start date
- Jun 2016
- Locations
- 39 sites, Japan
- Primary endpoint
- Change from baseline in weekly mean SBM frequency during one week of administration (Part I)